Frailty in Older Adults
11
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
Effects of a Community-based Multicomponent Physical Exercise Program on Physical Function, Frailty, and Sarcopenia in Older Adults From the Municipality of Santoña: a Quasi-experimental Study.
Comparison of Preoperative Frailty Assessment Tools
Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore
Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient
Postoperative Frailty Trajectories and One-Year Mortality in Older Surgical Patients
Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration
Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome
Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home
Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures
The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.
A Biopsychosocial Approach to Improving Multidimensional Frailty Status in Community-Dwelling Older Adults